Overview
Financials
Revenue history
Filing timeliness
No financial statement for 2023 – the filing deadline has passed. 4 of 4 financial statements were filed late (the longest delay 1934 days for 2019).
- 2023not filed
- 202205/02/2026
- 202131/01/2026
- 202031/01/2026
- 201931/01/2026
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2022.
Results vs industry
Industry
Authorized Representatives
Manner of representation
In the case of a multi-member management board, two members of the management board acting jointly or a member of the management board acting jointly with a commercial proxy are authorised to make declarations of will on behalf of the company. In the case of a one-person management board, a member of the management board (the President of the Management Board) acting independently is authorised to make declarations of will on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Witold Stanisław Płusaage 67 | 50 | $675.31 | 50% |
Ewa Werstak Mościckaage 50 | 50 | $675.31 | 50% |
Beneficial owners
| Person | Rights |
|---|---|
Subsidiaries
| Name | Share value | Stake | ||
|---|---|---|---|---|
Beauty Solutionssp. z o.o. | 675.31 USD | 50% |
Bank accounts
Was a VAT taxpayer from 2019-04-19 to 2024-03-07.
Reason for removal: Art. 96 ust. 9a pkt 1 (business activity suspended for at least 6 consecutive months)
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Anpharm Przedsiębiorstwo FarmaceutyczneS.A. | $111,469,394.21 | anpharm.pl | ||
| Tarchomińskie Zakłady Farmaceutyczne PolfaS.A. | $102,988,448.02 | polfa-tarchomin.com.pl | ||
| VercoS.A. | $43,577,172.02 | verco.com.pl | ||
| MedicofarmaS.A. | $8,530,473.72 | medicofarma.pl | ||
| VitamaS.A. | $4,287,087.38 | vitama.pl | ||
| Munar PharmaS.A. | $85,649.72 | munar.pl | ||
| Sanford Biotechsp. z o.o. | $2,586.64 | sanfordbiotech.com | ||
| Cefeasp. z o.o. | $294.66 | cefea.pl | ||
| Auxilius PharmaS.A. | $0.83 | auxiliuspharma.com | ||
| Stg25Branch (foreign co.) | – | glagolica.eu |
Change history
| Date | Event | |
|---|---|---|
| 2025-07-07 | Business suspended | |
| 2025-06-05 | Business resumed | |
| 2023-04-25 | Business suspended | |
| 2019-03-25 | Entered in the register |
FAQ
Last updated: 2026-04-11